newsfilter
← Latest News
GlobeNewswire·

LexaGene Finalizes Design of Pneumonia Panel

BEVERLY, Mass., Nov. 01, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB:LXXGF, TSXV:LXG) ("LexaGene" or the "Company"), a molecular diagnostics company that has commercialized an instrument for automated multiplex PCR testing for veterinary